Evidence map›Paper›PMID 35721434›Full record

ArticleIJID regions2022

SARS-CoV-2 viral dynamics of the first 1000 sequences from Vietnam and neighbouring ASEAN countries.

Nghiem Xuan Hoan, Srinivas Reddy Pallerla, Pham Xuan Huy, Hannah Krämer, Truong Nhat My, Tran Thanh Tung, Phan Quoc Hoan, Nguyen Linh Toan, Le Huu Song, Thirumalaisamy P Velavan

Abstract read
In one paragraph

Article in IJID regions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nghiem Xuan HoanDepartment of Molecular Biology, 108 Military Central Hospital, Hanoi, Vietnam.
Srinivas Reddy PallerlaVietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
Pham Xuan HuyVietnamese Military Medical University, Hanoi, Vietnam.
Hannah KrämerVietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
Truong Nhat MyVietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
Tran Thanh TungVietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
Phan Quoc HoanDepartment of Molecular Biology, 108 Military Central Hospital, Hanoi, Vietnam.
Nguyen Linh ToanVietnamese Military Medical University, Hanoi, Vietnam.
Le Huu SongDepartment of Molecular Biology, 108 Military Central Hospital, Hanoi, Vietnam.
Thirumalaisamy P VelavanVietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The regional distribution and transmissibility of existing COVID-19 variants of concern (VOC) has led to concerns about increasing transmission, given the ability of VOCs to evade immunity as breakthrough infections become more prevalent. Methods: SARS-CoV-2 genomes ( Results: Between January and November 8, 2021, VOCs, including alpha (B.1.1.7), beta (B.1.351), gamma (P.1), and delta (B.1.617.2), were observed across the ASEAN countries. While alpha and delta were the major VOCs in nine ASEAN countries, delta was predominant. The alpha VOC was first reported by Singapore, beta by Malaysia, gamma by the Philippines, and delta by Singapore. Of the first 1000 genomes analysed from Vietnam, alpha and delta were the most represented, with delta being the dominant VOC from May 2021. The delta variant was introduced in early January 2021, and formed a large cluster within the representative genomes. Conclusion: Spatial and temporal monitoring of SARS-CoV-2 variants is critical to the understanding of viral phylodynamics, and will provide useful guidance to policy makers for infection prevention and control.

Indexed as

ASEANB.1.614.2COVID-19delta variantSARS-CoV-2variants of concernVietnamVOC

Identifiers

PMID35721434
PMCPMC8770528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.